Articles

ESMH regularly publishes articles on topics related to science and new technologies that provoke a lot of media attention and that are important in the European context. Most importantly, the articles are written with the help of science writers in journalistic style and always provide the opinion of one or more scientists on the topic. The publications are accompanied by a selection of links to related information and with a focus on European research and knowledge in the field.

Light Bulbs Concept

Covid-19: What are the consequences of the unprecedented rush for knowledge?

The surge in COVID-19 research papers has put the spotlight on the peer review process and is changing the way we assess the quality of scientific literature.

Social distancing concept. Physical contamination, infected people.

Mix of COVID-19 cluster-busting with vaccine push may bring a new normal faster

Combining so-called “backward tracing” with traditional forward tracing to help identify source events of COVID-19 outbreaks has been cited as a potential way of better tracking the disease, as seen in some Asian countries. Now that vaccines are emerging on the scene, how can this concept be used for more effective cluster-busting?

European responses to the corona crisis – Part 13

During the Coronavirus crises, the European Science-Media Hub is collecting and publishing a regular update of the most relevant releases provided by EU institutions and other European and global actors. 🆕 Last Update : 12 Jan 2021

Newspapers on a laptop

Interview with Philipp Schmid on science denialism, misinformation & the importance of public confidence in the safety & effectiveness of the Covid-19 vaccine

Dr. Philipp Schmid is a scientific researcher at the Department of Psychology at the University of Erfurt (Germany). Philipp’s research aims at analysing the psychological reasons of science denialism. He is the lead author of the WHO guideline on how to respond to vocal vaccine denier in public and a co-author of the Debunking Handbook ...

truth lies text carved on wooden signpost outdoors in nature green soft forest bokeh in the background

What drives public trust? Broadening the traditional scope of science communication with TRESCA

The COVID-19 pandemic has accelerated the digitalisation of our daily lives and, by now, we are all a bit more dependent on technology than we had been before. But how can we trust all the scientific information that we receive through the media? How can we have a common understanding of what is reliable when we are being exposed to massive online information flows? Do we trust the same truths? What kind of people are more susceptible to trusting conspiracy theories? Using a novel approach based on social science, the new EU-funded project TRESCA tackles these, and other, research questions.

Man working near drawing son at home

The (digital) future of work in the post-Covid-19 era

The coronavirus pandemic has accelerated digitalization and the adoption of new technologies that are having a profound effect on the way we work. It has highlighted the urgent need to protect workers’ rights and to adopt measures that ensure inclusive growth and close the digital divide.

Bottles coronavirus vaccine. sars-cov-2 / COVID-19. Some ampoules with ncov-2019 vaccine in a box. to fight the coronavirus pandemic

Vaccination policy in times of Covid-19

As multiple COVID-19 vaccines are emerging, what can be done to tackle vaccination hesitancy and ensure rapid and equitable deployment?

injecting injection vaccine vaccination medicine flu woman doctor

COVID-19: ensuring a safe and effective vaccine

Scientists around the world are working hard to come up with a COVID-19 vaccine to suppress the pandemic. How can the EU guarantee that rapidly approved vaccines are safe and effective? We asked senior representatives from the European Medicines Agency (EMA) and the European Centre for Disease Prevention and Control (ECDC) for their thoughts.

Coronavirus Covid-19 treatment illustration banner

Tocilizumab : a treatment alternative in COVID-19 pneumonia

Patients with severe COVID-19 pneumonia often need to be mechanically intubated and have an increased mortality risk. Tocilizumab, a drug used against the cytokine storm underlying this clinical condition, has shown positive effects in clinical trials.

Coronavirus Covid-19 treatment illustration banner

The key role of antivirals in COVID-19 treatment

A few weeks after the SARS-CoV-2 was identified by Chinese researchers as the cause of ‘COVID-19’, an antiviral called remdesivir, originally used during the 2014 Ebola outbreak, came into play as the first available option to treat patients with coronavirus disease 2019 (COVID-19). Even if the approval process for remdesivir caused some controversy, experts consider the combined use of antivirals and other drugs a promising solution for treatment of Covid-19.